Presenter: Daniel O’Reilly and Joseph Ochaba (Oligonucleotide Therapeutics Society)
Date: November 19, 2019
With a constantly growing list of oligonucleotide therapies that are entering the clinics, these exciting research molecules-turned-therapeutic strategy are starting to lead the way in treatments for many devastating diseases. At their core, an Oligonucleotide therapeutic is a short synthetic DNA or RNA that is constructed to target a specific sequence of a gene. Whilst the concept is simple, converting this idea to an effective therapeutic required the development of changes to the properties of oligonucleotides.
We are excited to bring you this webinar series (19th November, 11 AM EST) which will give a brief introduction into the world of these types of medicines, how scientists create them in the lab, and how we can harness these medicines and apply them to treat various genetic diseases. From CRISPR to ASOs and siRNAs, we hope to break down the complex scientific jargon and walk you step-by-step through these exciting tools being used to treat patients around the world. In addition to these educational sessions, we will also discuss the Oligonucleotide Therapeutic Society (OTS) and how the society is fostering collaboration between patient groups and researchers for the development of novel therapeutics.